Literature DB >> 30105357

Determining Optimal Test Parameters for Assessing Dark Adaptation in People With Intermediate Age-Related Macular Degeneration.

Alison M Binns1, Deanna J Taylor1, Laura A Edwards1, David P Crabb1.   

Abstract

Purpose: The primary aim was to determine optimal test conditions for evaluating dark adaptation in intermediate age-related macular degeneration (iAMD) in order to minimize test time while maintaining diagnostic sensitivity.
Methods: People with AMD and age-similar controls were recruited (aged >55 years). Rod intercept time (RIT) was assessed after a 76%, 70%, and 65% rhodopsin bleach at 5° eccentricity and 76% and 70% bleach at 12°. Test order was randomized and a 30-minute washout period added between tests. Results were compared between control and iAMD groups and receiver operating characteristics (ROC) curves were constructed.
Results: A total of 26 participants with variable grades of macular health attended for two visits. There was a statistically significant difference in average RIT between the control and iAMD groups at 5° (median, IQR controls = 5.8 minutes, 3.8-7.5; iAMD = 20.6 minutes, 11.1-30.0; Mann-Whitney, P = 0.01) and at 12° (mean, controls: 4.54 minutes ± 2.12 SD, iAMD = 7.72 minutes ± 3.37 SD; independent samples t-test, P = 0.03) following a 76% bleach. Area under the ROC curves was 0.83 (confidence interval [CI]: 0.64-1.0) and 0.79 (CI: 0.59-0.99) for these two test conditions, respectively. Five participants (45%) in the iAMD group had RITs >20 minutes for 76% bleach at 5°, but none for any other test condition. Conclusions: Nearly half of the participants with iAMD produced unacceptably long recovery times (>20 minutes) using a 76% bleach at 5° eccentricity. The 76% bleach at 12° provided almost equivalent separation between AMD and controls but recovery was achieved within 20 minutes.

Entities:  

Mesh:

Year:  2018        PMID: 30105357     DOI: 10.1167/iovs.18-24211

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  [Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].

Authors:  Jan H Terheyden; Robert P Finger; Steffen Schmitz-Valckenberg; Hansjürgen Agostini; Claudia Dahlke; Laura Kuehlewein; Gabriele E Lang; Daniel Pauleikhoff; Armin Wolf; Michael K Boettger; Ulrich F O Luhmann; Friedrich Asmus; Frank G Holz
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  Evaluating the performance of the staircase and quick Change Detection methods in measuring perceptual learning.

Authors:  Pan Zhang; Yukai Zhao; Barbara Anne Dosher; Zhong-Lin Lu
Journal:  J Vis       Date:  2019-07-01       Impact factor: 2.240

3.  Delayed dark adaptation in central serous chorioretinopathy.

Authors:  Archana Nigalye; Shrinivas Pundlik; Janice Kim; Gang Luo; Deeba Husain
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-21

Review 4.  Dark Adaptation and Its Role in Age-Related Macular Degeneration.

Authors:  Archana K Nigalye; Kristina Hess; Shrinivas J Pundlik; Brett G Jeffrey; Catherine A Cukras; Deeba Husain
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

5.  Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.

Authors:  Pinakin Gunvant Davey; Thomas Henderson; Drake W Lem; Rebecca Weis; Stephanie Amonoo-Monney; David W Evans
Journal:  Nutrients       Date:  2020-10-26       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.